Physician profile
Robert D Grande
NPI 1891812574
$1,478.06
in general payments reported to CMS, 2019-2025
12 companies · $77.26 in 2025
The $77.26 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $17.25 · 2023: $271 · 2024: $980 · 2025: $77.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.50 |
| Travel and Lodging | $351.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $744.00 | 2024 | Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $369.21 | 2019-2024 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $107.97 | 2023-2025 | Camzyos, Eliquis |
| Atricure, INC. | $56.58 | 2024 | |
| Pfizer INC. | $52.90 | 2024-2025 | |
| Scpharmaceuticals INC. | $33.67 | 2024 | |
| Lantheus Medical Imaging, INC. | $25.36 | 2023 | Definity |
| Kestra Medical Technology Services, INC. | $24.98 | 2023 | Assure Wcd |
| Novo Nordisk INC | $20.94 | 2023 | Rybelsus, Ozempic |
| Medtronic, INC. | $17.25 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.